Legal Representation
Attorney
Susan A. Smith
USPTO Deadlines
Next Deadline
1801 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-06-18)
Due Date
June 18, 2030
Grace Period Ends
December 18, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
35 events| Date | Code | Type | Description |
|---|---|---|---|
| Jun 18, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Jun 18, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Apr 2, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Apr 2, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Mar 13, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Feb 29, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Feb 14, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Feb 14, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Feb 14, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Feb 8, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Feb 8, 2024 | GNRT | O | NON-FINAL ACTION E-MAILED |
| Feb 8, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Feb 7, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Feb 7, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Feb 5, 2024 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Feb 2, 2024 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Feb 2, 2024 | GNSL | S | LETTER OF SUSPENSION E-MAILED |
| Feb 2, 2024 | CNSL | R | SUSPENSION LETTER WRITTEN |
| Feb 2, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Feb 2, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Feb 2, 2024 | ALIE | A | ASSIGNED TO LIE |
| Jan 22, 2024 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Jan 22, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Jan 22, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Jan 22, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Sep 13, 2023 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Jul 6, 2023 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Jul 6, 2023 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED |
| Jul 6, 2023 | CNSI | R | SUSPENSION INQUIRY WRITTEN |
| Jan 5, 2023 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Jan 5, 2023 | GNSL | F | LETTER OF SUSPENSION E-MAILED |
| Jan 5, 2023 | CNSL | R | SUSPENSION LETTER WRITTEN |
| Dec 30, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
| Sep 27, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sep 15, 2022 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 042
Research and development relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; evaluation relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; consultancy relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; testing relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; research and development of pharmaceutical, biotech and vaccine products; consultancy relating to pharmaceutical, biotech and vaccine sectors; advisory services relating to research and development of pharmaceutical, biotech and vaccine products
Classification
International Classes
042
USPTO Documents
Click to view cached USPTO documents for this trademark
Only administrators can request new documents from USPTO